ᱮᱥᱮᱵᱤ ᱜᱩᱡᱨᱟᱴ ᱨᱮ ᱛᱮᱢᱤᱥ ᱵᱳᱭᱳᱥᱤᱱ ᱨᱮ فیملی ᱴᱨᱚᱥᱴ ᱦᱟᱢᱮᱴ ᱞᱟᱹᱜᱤᱫ ᱪᱷᱟᱹᱲ ᱮ ᱮᱢ ᱟᱠᱟᱫᱟ ᱾
ᱱᱚᱶᱟ ᱚᱰᱟᱨ ᱫᱚ ᱜᱩᱡᱨᱟᱴ ᱛᱮᱢᱤᱥ ᱵᱳᱭᱳᱥᱤᱱ ᱞᱤᱢᱤꯇꯦꯗ ᱨᱮ ᱥᱮᱭᱟᱨ ᱟᱨ ᱵᱷᱳᱴ ᱠᱚᱨᱟᱣ ᱨᱮᱭᱟᱜ ᱫᱟᱲᱮ ᱧᱟᱢ ᱨᱮᱭᱟᱜ ᱠᱟᱛᱷᱟ ᱥᱮᱵᱤ ᱨᱮᱭᱟᱜ ଟେକᱳᱵᱷᱟᱨ ریگᱤᱭᱩᱞᱮᱥᱚᱱ ᱨᱮᱭᱟᱜ ᱜᱚᱴᱟᱵᱩᱴᱟᱹ ᱵᱚᱱᱫᱮᱡ ᱠᱷᱚᱱ ᱵᱤᱵᱷᱤᱫᱢᱟᱨᱜ ٹرᱟᱥᱴ ᱫᱚ ᱪᱷᱟᱹᱲ ᱮ ᱮᱢ ᱟᱠᱟᱫᱟ ᱾ ᱱᱚᱶᱟ ᱦᱟᱢᱮᱴ ᱨᱮ ᱯᱚᱨᱚᱢᱳᱴᱟᱨ ᱦᱳᱞᱰᱤᱝ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱵᱚᱱᱫᱮᱡ ᱥᱮᱞᱮᱫ ᱢᱮᱱᱟᱜᱼᱟ ᱡᱟᱦᱟᱸ ᱨᱮ ᱥᱮᱭᱟᱨ ᱢᱤᱫᱴᱟᱝ ᱜᱷᱟᱨᱚᱸᱡᱽ ᱨᱮᱭᱟᱜ ᱴᱨᱚᱥᱴ ᱨᱮ ᱵᱚᱱᱫᱮᱡ ᱦᱩᱭᱩᱜᱼᱟ ᱾
Themis Biosyn Ltd (TAR), Vividhmargi Trust (Proposed Acquirer), Mr. (Settleor/Trustee), Pharmausutical Business Group (India) Ltd (PBGL), Themis Medicare Ltd (TML), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR), Themis Biosyn Ltd (TAR
- ᱥᱮᱵᱤ 2011 ᱥᱟᱹᱦᱤᱛ ᱨᱮᱭᱟᱜ ᱥᱮᱵᱤ (ᱥᱮᱭᱟᱨ ᱟᱨ ଟେକᱳᱵᱷᱟᱨ ᱨᱮᱭᱟᱜ ᱟᱹᱰᱤ ᱜᱟᱱ ᱮᱠᱩᱭᱤᱡᱮᱥᱚᱱ) ᱨᱮᱭᱟᱜ ᱨᱮᱜᱳᱞᱮᱥᱚᱱ 11 ᱨᱮᱭᱟᱜ ᱞᱟᱛᱟᱨ ᱨᱮ ᱢᱤᱫᱴᱟᱝ ᱪᱷᱟᱹᱲ ᱮ ᱮᱢ ᱞᱮᱫᱟ ᱾
- ᱱᱚᱶᱟ ᱪᱷᱟᱹᱲ ᱫᱚ ᱵᱤᱵᱷᱚᱫᱚᱢᱟᱨᱜ ٹرᱟᱥᱴ ᱫᱟᱨᱟᱭ ᱛᱮ ٹارᱜᱮᱴ ᱠᱳᱢᱯᱟᱱᱤ ᱨᱮ ᱥᱮᱭᱟᱨ ᱟᱨ ᱵᱷᱳᱴ ᱨᱮᱭᱟᱜ ᱥᱟᱹᱵᱩᱫ ᱥᱮᱭᱟᱨ ᱟᱨ ᱵᱷᱳᱴ ᱨᱮᱭᱟᱜ ᱫᱟᱲᱮ ᱞᱟᱹᱜᱤᱫ ᱵᱮᱣᱦᱟᱨᱚᱜᱼᱟ ᱾
- ᱯᱚᱨᱟᱢᱚᱥ ᱟᱠᱟᱱ ᱵᱚᱱᱫᱮᱡ ᱨᱮᱭᱟᱜ ᱢᱩᱫᱽᱨᱮ ᱢᱮᱱᱟᱜᱼᱟ ٹارᱜᱮᱴ ᱠᱳᱢᱯᱟᱱᱤ ᱨᱮᱭᱟᱜ ᱚᱱᱢᱟᱱ 0.61% ᱥᱮᱭᱟᱨ ᱥᱚᱨᱟᱥᱚᱨᱤ ᱴᱨᱚᱥᱴ ᱨᱮ ᱵᱚᱱᱫᱮᱡ ᱟᱨ ᱯᱮᱵᱤᱡᱤᱮᱞ (47.02 ᱴᱤᱥᱤ ᱨᱮᱭᱟᱜ%) ᱟᱨ ᱴᱤ ᱮᱢ ᱮᱞ (23.19 ᱴᱤᱥᱤ ᱨᱮᱭᱟᱜ%) ᱪᱮᱛᱟᱱ ᱵᱚᱱᱫᱮᱡ ᱦᱟᱛᱟᱣ ᱾
- ᱵᱤᱵᱷᱤᱫᱢᱚᱨᱜ ٹرᱟᱥᱴ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ 1882 ᱥᱟᱹᱦᱤᱛ ᱨᱮᱭᱟᱜ ᱵᱷᱟᱨᱚᱛᱤᱭᱚ ٹرᱟᱥᱴ ᱮᱠᱴ ᱨᱮᱭᱟᱜ ᱟᱶᱛᱟ ᱨᱮ ᱛᱷᱟᱯᱚᱱ ᱟᱠᱟᱱ ᱢᱤᱫᱴᱟᱝ ᱵᱟᱝ ᱵᱚᱱᱚᱫᱚᱞ ᱟᱱ, ᱩᱭᱦᱟᱹᱨᱟᱱ, ᱵᱮᱼᱵᱟᱹᱛᱟᱹᱨᱤ ٹرᱟᱥᱴ ᱾
- ᱚᱰᱟᱨ ᱨᱮ ᱞᱟᱹᱭ ᱟᱠᱟᱱᱟ ᱡᱮ, ᱯᱚᱨᱟᱢᱚᱥ ᱧᱟᱢ ᱠᱷᱟᱹᱛᱤᱨ ٹارᱜᱮᱴ ᱠᱳᱢᱯᱟᱱᱤ ᱨᱮᱭᱟᱜ ᱜᱩᱴ ᱢᱤᱫᱩᱭᱤᱴ ᱥᱮᱭᱟᱨ سرمائی ᱨᱮ ᱡᱟᱦᱟᱱ ᱵᱚᱱᱚᱫᱚᱞ ᱵᱟᱝ ᱦᱳᱭᱳᱜᱼᱟ ᱾
ᱮ ᱟᱭ ᱫᱟᱨᱟᱭ ᱛᱮ ᱱᱚᱛᱷᱚ ᱠᱷᱚᱱ ᱚᱞ, ᱟᱨ ᱚᱱᱟ ᱵᱤᱨᱩᱫᱷ ᱨᱮ ᱵᱤᱰᱟᱹᱣ ᱦᱩᱭ ᱟᱠᱟᱱᱟ ᱾ ᱞᱟᱛᱟᱨ ᱨᱮ ᱢᱩᱲᱩᱫ ᱫᱚ ᱥᱟᱹᱵᱩᱫ ᱟᱱᱟᱜ ᱾
ᱢᱩᱲᱩᱫ ᱱᱳᱴᱷᱤ ᱾
ᱱᱳᱴ ᱨᱮᱭᱟᱜ ᱵᱚᱨᱱᱚᱱ ᱾
| ᱥᱚᱨᱠᱟᱨᱤ ᱧᱩᱛᱩᱢ ᱾ | Themis Biosyn Ltd, SEBI (SAST) Regulation, 2011, Regulation 11 ᱾ |
| ᱥᱚᱨᱟᱥ ᱵᱳᱰᱤ ᱾ | ᱥᱮᱠᱩᱨᱤᱴᱤᱡᱽ ᱮᱱᱰ ᱮᱠᱪᱮᱱᱡᱽ ᱵᱳᱨᱰ ᱚᱯᱷ ᱤᱱᱰᱤᱭᱟ (ᱥᱮᱵᱤ)ᱼ ᱛᱷᱟᱯᱚᱱ ᱨᱮᱭᱟᱜ ᱚᱰᱟᱨ ᱾ |
| ᱵᱚᱨᱱᱚᱱ ᱱᱚᱢᱵᱚᱨ | WTM/KCV/CFD/24/2025-26 |
| ᱴᱷᱟᱶ ᱾ | ᱵᱚᱱᱚᱫᱚᱞ ᱦᱩᱭ ᱟᱠᱟᱱᱟ ᱾ (ᱚᱰᱟᱨ) |
| ᱥᱮᱨᱢᱟ ᱾ | 2026 |
| ᱢᱩᱪᱟᱹᱫ ᱨᱮᱭᱟᱜ ᱫᱤᱱ ᱾ | — |
| ᱱᱚᱛᱷᱚᱠᱚ ᱾ | 1 |